Zobrazeno 1 - 10
of 66
pro vyhledávání: '"O R McIntyre"'
Autor:
S L Rivers, W J Hammack, R A Kyle, L Wolfson, R F Ritchie, O R McIntyre, K J Bloch, A Sargent, Peter H. Schur, William C. Moloney
Publikováno v:
Scandinavian Journal of Haematology. 12:60-68
The possible role of IgG subclasses in patients with M-components or multiple myeloma was investigated. Among 900 patients with monoclonal proteins, the following IgG subclasses were identified: 77 % were IgG1; 14 % were IgG2; 6 % were IgG3; and 3 %
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56debaa3e966c02d56f88cca8393f85a
https://doi.org/10.1111/j.1600-0609.1974.tb00181.x
https://doi.org/10.1111/j.1600-0609.1974.tb00181.x
Autor:
E Greaves, R Allison, V Datton, Archie Bleyer, A Reiter, Harland N. Sather, S Murphy, C P Steuber, M F Auclerc, E C GordonSmith, Indraneel Mittra, Colin Baigent, A Solidoro, M Donnelly, Michael L. Hancock, M Cairo, D Sinclair, E Lepage, P A Shetty, C Harwood, Andrea Pession, R. D. Gelber, T Vietti, A Bancillon, D Mahoney, Richard Peto, V J Land, Santarelli, F SackmanMuriel, Maria Grazia Valsecchi, Giuseppe Masera, Mike Clarke, H Riehm, Richard Gray, C Perez, W Crist, H Duong, Michael E. Trigg, O R McIntyre, J Simone, Ching-Hon Pui, Jon Godwin, Paul S. Gaynon, Julian Peto, L Clavell, Keith Wheatley, J Chessells, Stephen E. Sallan, Martin Schrappe, O B Eden, S Richards, Roberto Rondelli, J Durrant, C Bailey, J Lilleyman, A Burnett, G Schaison, Gregory H. Reaman
Publikováno v:
The Lancet. 347:1783-1788
The effects on long-term outcome in childhood acute lymphoblastic leukaemia (ALL) of the duration and the intensity of maintenance chemotherapy need to be assessed reliably. With this objective the Childhood ALL Collaborative Group coordinated a worl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3b89bdfe5c7a3da7e5c82d96fdbbc1
https://doi.org/10.1016/s0140-6736(96)91615-3
https://doi.org/10.1016/s0140-6736(96)91615-3
Autor:
Roger B. Davis, O R McIntyre, Celia A. Schiffer, Joseph O. Moore, Deborah T. Berg, Bayard L. Powell, Frei E rd, George A. Omura, Robert J. Mayer, Philip Schulman
Publikováno v:
New England Journal of Medicine. 331:896-903
Background About 65 percent of previously untreated adults with primary acute myeloid leukemia (AML) enter complete remission when treated with cytarabine and an anthracycline. However, such responses are rarely durable when conventional postremissio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45eaddfde6fa823687c868c9237eb81b
https://doi.org/10.1056/nejm199410063311402
https://doi.org/10.1056/nejm199410063311402
Autor:
J Ellerton, H Ozer, Celia A. Schiffer, D Faragher, K Dear, M R Cooper, George P. Canellos, B Bernhardt, O R McIntyre, David B. Duggan
Publikováno v:
Journal of Clinical Oncology. 11:155-160
PURPOSE This clinical trial was designed to compare the effectiveness of the standard melphalan and prednisone regimen to that of melphalan, prednisone, and interferon in patients with untreated multiple myeloma. PATIENTS AND METHODS Between October
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bccaad3e42cc1add3fa72793d45910b
https://doi.org/10.1200/jco.1993.11.1.155
https://doi.org/10.1200/jco.1993.11.1.155
Publikováno v:
Journal of Clinical Oncology. 9:2219-2224
Two hundred ninety patients with a recent diagnosis of multiple myeloma were studied psychologically at the time of initial treatment. Physician- and patient-completed psychosocial scales were correlated with physical variables used to measure tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9addf334e7f4b357a54a03720866be3
https://doi.org/10.1200/jco.1991.9.12.2219
https://doi.org/10.1200/jco.1991.9.12.2219
Autor:
O R McIntyre, Celia A. Schiffer, Roger B. Davis, A J Gottlieb, S Kopel, Robert O. Dillman, Mark R. Green, S Caplan, R B Weiss, H Preisler
Publikováno v:
Blood. 78:2520-2526
Between 1982 and 1986, 326 evaluable patients with acute myeloid leukemia (AML) were randomized to receive cytarabine (Ara-C) at 200 mg/m2 (A200) or 100 mg/m2 (A100) for induction and maintenance therapy. Cycle 1 of induction therapy consisted of 7 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8062b8d6eb4fe74e5b71b4d268998f1
https://doi.org/10.1182/blood.v78.10.2520.2520
https://doi.org/10.1182/blood.v78.10.2520.2520
Autor:
O. R. McIntyre
During the 60 months of this project, 23 member institutions of the Cancer and Leukemia Group B (CALGB) and their affiliates entered 347 breast cancer patients into the Linked Registry according to procedures specified in CALCB protocol 9484. Telepho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ac5622e98f4cee634e9c2340a342ee
https://doi.org/10.21236/ada371250
https://doi.org/10.21236/ada371250
Publikováno v:
Cancer investigation. 14(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ee18769f88fbac5182a663543b8aaf0
https://pubmed.ncbi.nlm.nih.gov/8689435
https://pubmed.ncbi.nlm.nih.gov/8689435
Autor:
R J, Mayer, R B, Davis, C A, Schiffer, D T, Berg, B L, Powell, P, Schulman, G A, Omura, J O, Moore, O R, McIntyre, E, Frei
Publikováno v:
The New England journal of medicine. 331(14)
About 65 percent of previously untreated adults with primary acute myeloid leukemia (AML) enter complete remission when treated with cytarabine and an anthracycline. However, such responses are rarely durable when conventional postremission therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::feee2e6012cb05c1fbb025734f577b56
https://pubmed.ncbi.nlm.nih.gov/8078557
https://pubmed.ncbi.nlm.nih.gov/8078557
Autor:
C A, Schiffer, O R, McIntyre
Publikováno v:
Advances in experimental medicine and biology. 330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9803c99246c90c95962f9c49294b3666
https://pubmed.ncbi.nlm.nih.gov/8368134
https://pubmed.ncbi.nlm.nih.gov/8368134